ENETS-INCA NET Cancer Day Webinar

By Leanne Talbot

Posted 5 years ago

13/10/2021 9am

Please join us and take part in the ENETS-INCA NET Cancer Day Educational Webinar on Wednesday  10 November 2021, from 12:00 – 14:15 Central European Time (CET) – (11am – 1:15pm)

This webinar is designed for patients and patient advocates, and is free of charge. No registration is necessary – you do not need to be an ENETS member! If you have any technical issues, please contact the ENETS Office at [email protected].

Webinar agenda

12:00 – 12:10 | OPENING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

12:10 – 12:40 | PART ONE | The Facts: Incidence and prevalence of NENs globally

Gregory KALTSAS (Endocrinologist, GRE) and Staffan WELIN (Endocrine Oncologist, SWE)

12:10 – 12:20  Talk

12:20 – 12:40  Q+A session

12:40 – 13:10 | PART TWO | Patient reported treatment side effects: What causes the side effects in NEN treatments and strategies for side effect management

Angela LAMARCA (Oncologist, GBR) and Simona GLASBERG (Endocrinologist, ISR)

12:40 – 12:50  Talk

12:50 – 13:10  Q+A session

13:10 – 13:40 | PART THREE | Patients as partners in NEN Research: Key focal points of research from genomics to organoids. What is it all telling us, and are patient views being truly considered?

  • Where are we now, what do we know, and what do we need to further investigate?
  • Role of patients in research

Enrique GRANDE (Oncologist, ESP) and Anja RINKE (Gastroenterologist, GER)

13:10 – 13:20  Talk

13:20 – 13:40  Q+A session

13:40 – 14:10 | PART FOUR | Nutrition in NENs

  • Patient case history given by the patient around issues with diet and nutrition. A dietician, doctor and nurse offering solutions to these issues.

Wanda GEILVOET (Nurse, NED), Dietitian (tbd), and Elisabeth NIEVEEN VAN DIJKUM (Surgeon, NED)

13:40 – 13:50  Talk

13:50 – 14:10  Q+A session

14:10 – 14:15 | CLOSING

Catherine BOUVIER (INCA President, GBR) and Marianne PAVEL (ENETS Chair, GER)

CLICK HERE TO VIEW THE EVENT.

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...